Co-Authors
This is a "connection" page, showing publications co-authored by Emanuele Montomoli and Serena Marchi.
Connection Strength
1.042
-
Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients. Viruses. 2021 07 12; 13(7).
Score: 0.239
-
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection. PLoS One. 2021; 16(7):e0253977.
Score: 0.239
-
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples. J Immunol Methods. 2021 02; 489:112937.
Score: 0.229
-
Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples. J Med Virol. 2020 10; 92(10):2096-2104.
Score: 0.221
-
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2. Eur J Med Chem. 2021 Nov 15; 224:113683.
Score: 0.060
-
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy. Eur J Intern Med. 2020 08; 78:161-163.
Score: 0.055